Case File
efta-01454265DOJ Data Set 10OtherEFTA01454265
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01454265
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
jeffrey E. [[email protected])
Sent:
5/20/2014 9:41:53 AM
To:
Tazia Smith
CC:
Paul Morris
; Vinit Sahni
; Nav Gupta I
I; Richard Kahn
; Vahe Stepanian
Subject:
Re: Long Equity: Consider $1mm Brookdale Senior Living on macro/micro tailwinds (- 30% upside to $42 tgt) IC)
i want to play a stronger rupee 9 month horizon
On Tue, May 20, 2014 at 9:33 AM, Tazia Smith <MMI
wrote:
Classification: Confidential
Jeffrey -
Focusing on listed/exchange traded opportunities:
Consider buying $1-2mm position in Brookdale Senior Living (BKD)
Macro Trend: Baby boomers retiring and aging population
Micro: Merger tailwinds, pro-forma valuation upside and broader investor demand
Brookdale Senior Living (BKD)
Closed 5/19: $32.06 ($32.40 last)
$3.8bn mkt cap (trades 1.3mm shs a day avg)
$42 DB 12mo price target (implies -30% upside) vs. 37.71 cons (-16%)
Catalyst: merger proxy filing expected this month (Brookdale bid to acquire Emeritus, ESC ($1.4bn
mkt cap), in late Feb for $2.8bn in stock; est merger completion is 3Q14)
Valuation: $42 = 12x proforma BKD+ESC 2015 CFFO/sh of $3.40
a.
Strong Industry Fndamentals
b.
BKD's market leadership (10% pro forma market share and attractive national footprint +
management team and corporate infrastructure lending itself to leverage/scale)
c.
Mid-teen's growth characteristics with organic 6-8% and accretion from the ESC acquisition
adding 8-10% for the next 2-3 years (ests = +18% in 2015 and + 27% in 2016). Q1 earnings report no
5/8, BKD posted its third consecutive quarter of double digit CFFO growth
d.
Current Valuation: 9.1x pro-forma 2015 CFFO/sh and just shy of 10x on a stand alone basis
(8.9x pro-forma 2015 EV/EBITDA, 11.6x stand-alone)
e.
Market Cap — pro-forma will be greater than $5bn, expected to deliver broader investor interest
Key risks include: competition, new supply, capex requirements to upgrade Emeritus' portfolio,
merger approvals, housing market, interest rate sensitivity
CFFO = cash flow from operations
https://qer.qm.cib.intranet.db.com/qer/document/pdf/0900b8c088436c25.pdf
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 112268
CONFIDENTIAL
SDNY_GM_00258452
EFTA01454265
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
https://qer.qm.cib.intranet.db.com/qer/document/pdf/0900b8c088436c25.pdfRelated Documents (6)
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01474808
0p
DOJ Data Set 9OtherUnknown
From: "jeffrey E." <jeevacationggmail.com>
3p
DOJ Data Set 9OtherUnknown
From: Vahe Stepanian
6p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01459963
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01365873
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01457165
0p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.